0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Irreversible Electroporation Ablation Device Market Research Report 2026
Published Date: 2026-03-02
|
Report Code: QYRE-Auto-23Y19922
Home | Market Reports | Health| Medical Devices & Equipment
Global Irreversible Electroporation Ablation Device Market Research Report 2026
BUY CHAPTERS

Global Irreversible Electroporation Ablation Device Market Research Report 2026

Code: QYRE-Auto-23Y19922
Report
2026-03-02
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Irreversible Electroporation Ablation Device Market Size

The global Irreversible Electroporation Ablation Device market was valued at US$ 139 million in 2025 and is anticipated to reach US$ 207 million by 2032, at a CAGR of 5.8% from 2026 to 2032.

Irreversible Electroporation Ablation Device Market

Irreversible Electroporation Ablation Device Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Irreversible Electroporation Ablation Device competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
An irreversible electroporation ablation device is an advanced medical system that performs non-thermal ablation of tumor tissue by applying high-voltage pulsed electric fields. By placing multi-channel electrodes around the target lesion and delivering short, high-intensity electrical pulses, the device induces permanent nanopores in cell membranes, leading to apoptosis and selective tissue destruction while preserving surrounding critical structures such as blood vessels, bile ducts, and nerves. The system typically consists of a high-voltage pulse generator, electrode probes, control and monitoring modules, image-navigation interfaces, and data-processing software. Key upstream inputs include high-voltage electronic modules, medical-grade titanium alloy or stainless-steel electrodes, insulating coatings, and precision mechanical components. Downstream customers primarily include general hospitals, cancer centers, cardiac centers, interventional departments, and research institutions, with applications spanning tumor ablation, tissue modulation, and experimental bioelectrical therapies. In 2025, global nameplate capacity is estimated at approximately 1,050 units, with actual sales of about 878 units, an average selling price of around USD 165,000 per unit, and industry gross margins typically ranging from 25% to 40%. Supported by growing demand for minimally invasive therapies and advances in precision imaging integration, the market is expected to maintain steady expansion.
The North American market for Irreversible Electroporation Ablation Device is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Irreversible Electroporation Ablation Device is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Irreversible Electroporation Ablation Device include AngioDynamics, Pulse Biosciences, Surgnova, Alpmed, Shanghai Nortion Medical Technology, Hangzhou Ready Biological Technology, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Irreversible Electroporation Ablation Device market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Irreversible Electroporation Ablation Device. The Irreversible Electroporation Ablation Device market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Irreversible Electroporation Ablation Device market comprehensively. Regional market sizes by Type, by Application, by End-User, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Irreversible Electroporation Ablation Device manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Irreversible Electroporation Ablation Device Market Report

Report Metric Details
Report Name Irreversible Electroporation Ablation Device Market
Accounted market size in 2025 US$ 139 million
Forecasted market size in 2032 US$ 207 million
CAGR 5.8%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Classic IRE
  • nsPEF
  • Other
Segment by End-User
  • Hospital
  • Clinic
  • Other
by Application
  • Oncology Ablation
  • Cardiac Ablation
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AngioDynamics, Pulse Biosciences, Surgnova, Alpmed, Shanghai Nortion Medical Technology, Hangzhou Ready Biological Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by End-User, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Irreversible Electroporation Ablation Device manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Irreversible Electroporation Ablation Device sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Irreversible Electroporation Ablation Device Market growing?

Ans: The Irreversible Electroporation Ablation Device Market witnessing a CAGR of 5.8% during the forecast period 2026-2032.

What is the Irreversible Electroporation Ablation Device Market size in 2032?

Ans: The Irreversible Electroporation Ablation Device Market size in 2032 will be US$ 207 million.

Who are the main players in the Irreversible Electroporation Ablation Device Market report?

Ans: The main players in the Irreversible Electroporation Ablation Device Market are AngioDynamics, Pulse Biosciences, Surgnova, Alpmed, Shanghai Nortion Medical Technology, Hangzhou Ready Biological Technology

What are the Application segmentation covered in the Irreversible Electroporation Ablation Device Market report?

Ans: The Applications covered in the Irreversible Electroporation Ablation Device Market report are Oncology Ablation, Cardiac Ablation, Other

What are the Type segmentation covered in the Irreversible Electroporation Ablation Device Market report?

Ans: The Types covered in the Irreversible Electroporation Ablation Device Market report are Classic IRE, nsPEF, Other

1 Irreversible Electroporation Ablation Device Market Overview
1.1 Product Definition
1.2 Irreversible Electroporation Ablation Device by Type
1.2.1 Global Irreversible Electroporation Ablation Device Market Value by Type: 2025 vs 2032
1.2.2 Classic IRE
1.2.3 nsPEF
1.2.4 Other
1.3 Irreversible Electroporation Ablation Device by End-User
1.3.1 Global Irreversible Electroporation Ablation Device Market Value by End-User: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Irreversible Electroporation Ablation Device by Application
1.4.1 Global Irreversible Electroporation Ablation Device Market Value by Application: 2025 vs 2032
1.4.2 Oncology Ablation
1.4.3 Cardiac Ablation
1.4.4 Other
1.5 Global Irreversible Electroporation Ablation Device Market Size Estimates and Forecasts
1.5.1 Global Irreversible Electroporation Ablation Device Revenue 2021–2032
1.5.2 Global Irreversible Electroporation Ablation Device Sales 2021–2032
1.5.3 Global Irreversible Electroporation Ablation Device Market Average Price (2021–2032)
1.6 Assumptions and Limitations
2 Irreversible Electroporation Ablation Device Market Competition by Manufacturers
2.1 Global Irreversible Electroporation Ablation Device Sales Market Share by Manufacturers (2021–2026)
2.2 Global Irreversible Electroporation Ablation Device Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Irreversible Electroporation Ablation Device Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Irreversible Electroporation Ablation Device, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Irreversible Electroporation Ablation Device, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Irreversible Electroporation Ablation Device, Product Types and Applications
2.7 Global Key Manufacturers of Irreversible Electroporation Ablation Device, Date of Entry into the Industry
2.8 Global Irreversible Electroporation Ablation Device Market Competitive Situation and Trends
2.8.1 Global Irreversible Electroporation Ablation Device Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Irreversible Electroporation Ablation Device Players Market Share by Revenue
2.8.3 Global Irreversible Electroporation Ablation Device Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Irreversible Electroporation Ablation Device Market Scenario by Region
3.1 Global Irreversible Electroporation Ablation Device Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Irreversible Electroporation Ablation Device Sales by Region: 2021–2032
3.2.1 Global Irreversible Electroporation Ablation Device Sales by Region: 2021–2026
3.2.2 Global Irreversible Electroporation Ablation Device Sales by Region: 2027–2032
3.3 Global Irreversible Electroporation Ablation Device Revenue by Region: 2021–2032
3.3.1 Global Irreversible Electroporation Ablation Device Revenue by Region: 2021–2026
3.3.2 Global Irreversible Electroporation Ablation Device Revenue by Region: 2027–2032
3.4 North America Irreversible Electroporation Ablation Device Market Facts & Figures by Country
3.4.1 North America Irreversible Electroporation Ablation Device Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Irreversible Electroporation Ablation Device Sales by Country (2021–2032)
3.4.3 North America Irreversible Electroporation Ablation Device Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Irreversible Electroporation Ablation Device Market Facts & Figures by Country
3.5.1 Europe Irreversible Electroporation Ablation Device Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Irreversible Electroporation Ablation Device Sales by Country (2021–2032)
3.5.3 Europe Irreversible Electroporation Ablation Device Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Irreversible Electroporation Ablation Device Market Facts & Figures by Region
3.6.1 Asia Pacific Irreversible Electroporation Ablation Device Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Irreversible Electroporation Ablation Device Sales by Region (2021–2032)
3.6.3 Asia Pacific Irreversible Electroporation Ablation Device Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Irreversible Electroporation Ablation Device Market Facts & Figures by Country
3.7.1 Latin America Irreversible Electroporation Ablation Device Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Irreversible Electroporation Ablation Device Sales by Country (2021–2032)
3.7.3 Latin America Irreversible Electroporation Ablation Device Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Irreversible Electroporation Ablation Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Irreversible Electroporation Ablation Device Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Irreversible Electroporation Ablation Device Sales by Country (2021–2032)
3.8.3 Middle East and Africa Irreversible Electroporation Ablation Device Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Irreversible Electroporation Ablation Device Sales by Type (2021–2032)
4.1.1 Global Irreversible Electroporation Ablation Device Sales by Type (2021–2026)
4.1.2 Global Irreversible Electroporation Ablation Device Sales by Type (2027–2032)
4.1.3 Global Irreversible Electroporation Ablation Device Sales Market Share by Type (2021–2032)
4.2 Global Irreversible Electroporation Ablation Device Revenue by Type (2021–2032)
4.2.1 Global Irreversible Electroporation Ablation Device Revenue by Type (2021–2026)
4.2.2 Global Irreversible Electroporation Ablation Device Revenue by Type (2027–2032)
4.2.3 Global Irreversible Electroporation Ablation Device Revenue Market Share by Type (2021–2032)
4.3 Global Irreversible Electroporation Ablation Device Price by Type (2021–2032)
5 Segment by Application
5.1 Global Irreversible Electroporation Ablation Device Sales by Application (2021–2032)
5.1.1 Global Irreversible Electroporation Ablation Device Sales by Application (2021–2026)
5.1.2 Global Irreversible Electroporation Ablation Device Sales by Application (2027–2032)
5.1.3 Global Irreversible Electroporation Ablation Device Sales Market Share by Application (2021–2032)
5.2 Global Irreversible Electroporation Ablation Device Revenue by Application (2021–2032)
5.2.1 Global Irreversible Electroporation Ablation Device Revenue by Application (2021–2026)
5.2.2 Global Irreversible Electroporation Ablation Device Revenue by Application (2027–2032)
5.2.3 Global Irreversible Electroporation Ablation Device Revenue Market Share by Application (2021–2032)
5.3 Global Irreversible Electroporation Ablation Device Price by Application (2021–2032)
6 Key Companies Profiled
6.1 AngioDynamics
6.1.1 AngioDynamics Company Information
6.1.2 AngioDynamics Description and Business Overview
6.1.3 AngioDynamics Irreversible Electroporation Ablation Device Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 AngioDynamics Irreversible Electroporation Ablation Device Product Portfolio
6.1.5 AngioDynamics Recent Developments/Updates
6.2 Pulse Biosciences
6.2.1 Pulse Biosciences Company Information
6.2.2 Pulse Biosciences Description and Business Overview
6.2.3 Pulse Biosciences Irreversible Electroporation Ablation Device Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Pulse Biosciences Irreversible Electroporation Ablation Device Product Portfolio
6.2.5 Pulse Biosciences Recent Developments/Updates
6.3 Surgnova
6.3.1 Surgnova Company Information
6.3.2 Surgnova Description and Business Overview
6.3.3 Surgnova Irreversible Electroporation Ablation Device Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Surgnova Irreversible Electroporation Ablation Device Product Portfolio
6.3.5 Surgnova Recent Developments/Updates
6.4 Alpmed
6.4.1 Alpmed Company Information
6.4.2 Alpmed Description and Business Overview
6.4.3 Alpmed Irreversible Electroporation Ablation Device Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Alpmed Irreversible Electroporation Ablation Device Product Portfolio
6.4.5 Alpmed Recent Developments/Updates
6.5 Shanghai Nortion Medical Technology
6.5.1 Shanghai Nortion Medical Technology Company Information
6.5.2 Shanghai Nortion Medical Technology Description and Business Overview
6.5.3 Shanghai Nortion Medical Technology Irreversible Electroporation Ablation Device Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Shanghai Nortion Medical Technology Irreversible Electroporation Ablation Device Product Portfolio
6.5.5 Shanghai Nortion Medical Technology Recent Developments/Updates
6.6 Hangzhou Ready Biological Technology
6.6.1 Hangzhou Ready Biological Technology Company Information
6.6.2 Hangzhou Ready Biological Technology Description and Business Overview
6.6.3 Hangzhou Ready Biological Technology Irreversible Electroporation Ablation Device Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Hangzhou Ready Biological Technology Irreversible Electroporation Ablation Device Product Portfolio
6.6.5 Hangzhou Ready Biological Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Irreversible Electroporation Ablation Device Industry Chain Analysis
7.2 Irreversible Electroporation Ablation Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Irreversible Electroporation Ablation Device Production Mode & Process Analysis
7.4 Irreversible Electroporation Ablation Device Sales and Marketing
7.4.1 Irreversible Electroporation Ablation Device Sales Channels
7.4.2 Irreversible Electroporation Ablation Device Distributors
7.5 Irreversible Electroporation Ablation Device Customer Analysis
8 Irreversible Electroporation Ablation Device Market Dynamics
8.1 Irreversible Electroporation Ablation Device Industry Trends
8.2 Irreversible Electroporation Ablation Device Market Drivers
8.3 Irreversible Electroporation Ablation Device Market Challenges
8.4 Irreversible Electroporation Ablation Device Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Irreversible Electroporation Ablation Device Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Irreversible Electroporation Ablation Device Market Value by End-User (US$ Million), 2025 vs 2032
 Table 3. Global Irreversible Electroporation Ablation Device Market Value by Application (US$ Million), 2025 vs 2032
 Table 4. Global Irreversible Electroporation Ablation Device Market Competitive Situation by Manufacturers in 2025
 Table 5. Global Irreversible Electroporation Ablation Device Sales (Units) of Key Manufacturers (2021–2026)
 Table 6. Global Irreversible Electroporation Ablation Device Sales Market Share by Manufacturers (2021–2026)
 Table 7. Global Irreversible Electroporation Ablation Device Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 8. Global Irreversible Electroporation Ablation Device Revenue Share by Manufacturers (2021–2026)
 Table 9. Global Market Irreversible Electroporation Ablation Device Average Price (K US$/Unit) of Key Manufacturers (2021–2026)
 Table 10. Global Key Players of Irreversible Electroporation Ablation Device, Industry Ranking, 2023 vs 2024 vs 2025
 Table 11. Global Key Manufacturers of Irreversible Electroporation Ablation Device, Manufacturing Sites and Headquarters
 Table 12. Global Key Manufacturers of Irreversible Electroporation Ablation Device, Product Types and Applications
 Table 13. Global Key Manufacturers of Irreversible Electroporation Ablation Device, Date of Entry into the Industry
 Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Global Irreversible Electroporation Ablation Device Companies by Tier (Tier 1, Tier 2, Tier 3), based on Irreversible Electroporation Ablation Device Revenue, 2025
 Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 17. Global Irreversible Electroporation Ablation Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 18. Global Irreversible Electroporation Ablation Device Sales by Region (Units), 2021–2026
 Table 19. Global Irreversible Electroporation Ablation Device Sales Market Share by Region (2021–2026)
 Table 20. Global Irreversible Electroporation Ablation Device Sales by Region (Units), 2027–2032
 Table 21. Global Irreversible Electroporation Ablation Device Sales Market Share by Region (2027–2032)
 Table 22. Global Irreversible Electroporation Ablation Device Revenue by Region (US$ Million), 2021–2026
 Table 23. Global Irreversible Electroporation Ablation Device Revenue Market Share by Region (2021–2026)
 Table 24. Global Irreversible Electroporation Ablation Device Revenue by Region (US$ Million), 2027–2032
 Table 25. Global Irreversible Electroporation Ablation Device Revenue Market Share by Region (2027–2032)
 Table 26. North America Irreversible Electroporation Ablation Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 27. North America Irreversible Electroporation Ablation Device Sales by Country (Units), 2021–2026
 Table 28. North America Irreversible Electroporation Ablation Device Sales by Country (Units), 2027–2032
 Table 29. North America Irreversible Electroporation Ablation Device Revenue by Country (US$ Million), 2021–2026
 Table 30. North America Irreversible Electroporation Ablation Device Revenue by Country (US$ Million), 2027–2032
 Table 31. Europe Irreversible Electroporation Ablation Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 32. Europe Irreversible Electroporation Ablation Device Sales by Country (Units), 2021–2026
 Table 33. Europe Irreversible Electroporation Ablation Device Sales by Country (Units), 2027–2032
 Table 34. Europe Irreversible Electroporation Ablation Device Revenue by Country (US$ Million), 2021–2026
 Table 35. Europe Irreversible Electroporation Ablation Device Revenue by Country (US$ Million), 2027–2032
 Table 36. Asia Pacific Irreversible Electroporation Ablation Device Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 37. Asia Pacific Irreversible Electroporation Ablation Device Sales by Region (Units), 2021–2026
 Table 38. Asia Pacific Irreversible Electroporation Ablation Device Sales by Region (Units), 2027–2032
 Table 39. Asia Pacific Irreversible Electroporation Ablation Device Revenue by Region (US$ Million), 2021–2026
 Table 40. Asia Pacific Irreversible Electroporation Ablation Device Revenue by Region (US$ Million), 2027–2032
 Table 41. Latin America Irreversible Electroporation Ablation Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 42. Latin America Irreversible Electroporation Ablation Device Sales by Country (Units), 2021–2026
 Table 43. Latin America Irreversible Electroporation Ablation Device Sales by Country (Units), 2027–2032
 Table 44. Latin America Irreversible Electroporation Ablation Device Revenue by Country (US$ Million), 2021–2026
 Table 45. Latin America Irreversible Electroporation Ablation Device Revenue by Country (US$ Million), 2027–2032
 Table 46. Middle East and Africa Irreversible Electroporation Ablation Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 47. Middle East and Africa Irreversible Electroporation Ablation Device Sales by Country (Units), 2021–2026
 Table 48. Middle East and Africa Irreversible Electroporation Ablation Device Sales by Country (Units), 2027–2032
 Table 49. Middle East and Africa Irreversible Electroporation Ablation Device Revenue by Country (US$ Million), 2021–2026
 Table 50. Middle East and Africa Irreversible Electroporation Ablation Device Revenue by Country (US$ Million), 2027–2032
 Table 51. Global Irreversible Electroporation Ablation Device Sales (Units) by Type (2021–2026)
 Table 52. Global Irreversible Electroporation Ablation Device Sales (Units) by Type (2027–2032)
 Table 53. Global Irreversible Electroporation Ablation Device Sales Market Share by Type (2021–2026)
 Table 54. Global Irreversible Electroporation Ablation Device Sales Market Share by Type (2027–2032)
 Table 55. Global Irreversible Electroporation Ablation Device Revenue (US$ Million) by Type (2021–2026)
 Table 56. Global Irreversible Electroporation Ablation Device Revenue (US$ Million) by Type (2027–2032)
 Table 57. Global Irreversible Electroporation Ablation Device Revenue Market Share by Type (2021–2026)
 Table 58. Global Irreversible Electroporation Ablation Device Revenue Market Share by Type (2027–2032)
 Table 59. Global Irreversible Electroporation Ablation Device Price (K US$/Unit) by Type (2021–2026)
 Table 60. Global Irreversible Electroporation Ablation Device Price (K US$/Unit) by Type (2027–2032)
 Table 61. Global Irreversible Electroporation Ablation Device Sales (Units) by Application (2021–2026)
 Table 62. Global Irreversible Electroporation Ablation Device Sales (Units) by Application (2027–2032)
 Table 63. Global Irreversible Electroporation Ablation Device Sales Market Share by Application (2021–2026)
 Table 64. Global Irreversible Electroporation Ablation Device Sales Market Share by Application (2027–2032)
 Table 65. Global Irreversible Electroporation Ablation Device Revenue (US$ Million) by Application (2021–2026)
 Table 66. Global Irreversible Electroporation Ablation Device Revenue (US$ Million) by Application (2027–2032)
 Table 67. Global Irreversible Electroporation Ablation Device Revenue Market Share by Application (2021–2026)
 Table 68. Global Irreversible Electroporation Ablation Device Revenue Market Share by Application (2027–2032)
 Table 69. Global Irreversible Electroporation Ablation Device Price (K US$/Unit) by Application (2021–2026)
 Table 70. Global Irreversible Electroporation Ablation Device Price (K US$/Unit) by Application (2027–2032)
 Table 71. AngioDynamics Company Information
 Table 72. AngioDynamics Description and Business Overview
 Table 73. AngioDynamics Irreversible Electroporation Ablation Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 74. AngioDynamics Irreversible Electroporation Ablation Device Product
 Table 75. AngioDynamics Recent Developments/Updates
 Table 76. Pulse Biosciences Company Information
 Table 77. Pulse Biosciences Description and Business Overview
 Table 78. Pulse Biosciences Irreversible Electroporation Ablation Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 79. Pulse Biosciences Irreversible Electroporation Ablation Device Product
 Table 80. Pulse Biosciences Recent Developments/Updates
 Table 81. Surgnova Company Information
 Table 82. Surgnova Description and Business Overview
 Table 83. Surgnova Irreversible Electroporation Ablation Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 84. Surgnova Irreversible Electroporation Ablation Device Product
 Table 85. Surgnova Recent Developments/Updates
 Table 86. Alpmed Company Information
 Table 87. Alpmed Description and Business Overview
 Table 88. Alpmed Irreversible Electroporation Ablation Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 89. Alpmed Irreversible Electroporation Ablation Device Product
 Table 90. Alpmed Recent Developments/Updates
 Table 91. Shanghai Nortion Medical Technology Company Information
 Table 92. Shanghai Nortion Medical Technology Description and Business Overview
 Table 93. Shanghai Nortion Medical Technology Irreversible Electroporation Ablation Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 94. Shanghai Nortion Medical Technology Irreversible Electroporation Ablation Device Product
 Table 95. Shanghai Nortion Medical Technology Recent Developments/Updates
 Table 96. Hangzhou Ready Biological Technology Company Information
 Table 97. Hangzhou Ready Biological Technology Description and Business Overview
 Table 98. Hangzhou Ready Biological Technology Irreversible Electroporation Ablation Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 99. Hangzhou Ready Biological Technology Irreversible Electroporation Ablation Device Product
 Table 100. Hangzhou Ready Biological Technology Recent Developments/Updates
 Table 101. Key Raw Materials Lists
 Table 102. Raw Materials Key Suppliers Lists
 Table 103. Irreversible Electroporation Ablation Device Distributors List
 Table 104. Irreversible Electroporation Ablation Device Customers List
 Table 105. Irreversible Electroporation Ablation Device Market Trends
 Table 106. Irreversible Electroporation Ablation Device Market Drivers
 Table 107. Irreversible Electroporation Ablation Device Market Challenges
 Table 108. Irreversible Electroporation Ablation Device Market Restraints
 Table 109. Research Programs/Design for This Report
 Table 110. Key Data Information from Secondary Sources
 Table 111. Key Data Information from Primary Sources
 Table 112. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Irreversible Electroporation Ablation Device
 Figure 2. Global Irreversible Electroporation Ablation Device Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Irreversible Electroporation Ablation Device Market Share by Type: 2025 & 2032
 Figure 4. Classic IRE Product Picture
 Figure 5. nsPEF Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Irreversible Electroporation Ablation Device Market Value by End-User (US$ Million), 2021–2032
 Figure 8. Global Irreversible Electroporation Ablation Device Market Share by End-User: 2025 vs 2032
 Figure 9. Hospital Product Picture
 Figure 10. Clinic Product Picture
 Figure 11. Other Product Picture
 Figure 12. Global Irreversible Electroporation Ablation Device Market Value by Application (US$ Million), 2021–2032
 Figure 13. Global Irreversible Electroporation Ablation Device Market Share by Application: 2025 & 2032
 Figure 14. Oncology Ablation
 Figure 15. Cardiac Ablation
 Figure 16. Other
 Figure 17. Global Irreversible Electroporation Ablation Device Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 18. Global Irreversible Electroporation Ablation Device Market Size (US$ Million), 2021–2032
 Figure 19. Global Irreversible Electroporation Ablation Device Sales (Units), 2021–2032
 Figure 20. Global Irreversible Electroporation Ablation Device Average Price (K US$/Unit), 2021–2032
 Figure 21. Irreversible Electroporation Ablation Device Report Years Considered
 Figure 22. Irreversible Electroporation Ablation Device Sales Share by Manufacturers in 2025
 Figure 23. Global Irreversible Electroporation Ablation Device Revenue Share by Manufacturers in 2025
 Figure 24. Top 5 and Top 10 Global Irreversible Electroporation Ablation Device Players: Market Share by Revenue in Irreversible Electroporation Ablation Device in 2025
 Figure 25. Irreversible Electroporation Ablation Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 26. Global Irreversible Electroporation Ablation Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 27. North America Irreversible Electroporation Ablation Device Sales Market Share by Country (2021–2032)
 Figure 28. North America Irreversible Electroporation Ablation Device Revenue Market Share by Country (2021–2032)
 Figure 29. United States Irreversible Electroporation Ablation Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Canada Irreversible Electroporation Ablation Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Europe Irreversible Electroporation Ablation Device Sales Market Share by Country (2021–2032)
 Figure 32. Europe Irreversible Electroporation Ablation Device Revenue Market Share by Country (2021–2032)
 Figure 33. Germany Irreversible Electroporation Ablation Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. France Irreversible Electroporation Ablation Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. U.K. Irreversible Electroporation Ablation Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Italy Irreversible Electroporation Ablation Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Russia Irreversible Electroporation Ablation Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Asia Pacific Irreversible Electroporation Ablation Device Sales Market Share by Region (2021–2032)
 Figure 39. Asia Pacific Irreversible Electroporation Ablation Device Revenue Market Share by Region (2021–2032)
 Figure 40. China Irreversible Electroporation Ablation Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Japan Irreversible Electroporation Ablation Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. South Korea Irreversible Electroporation Ablation Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. India Irreversible Electroporation Ablation Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Australia Irreversible Electroporation Ablation Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. China Taiwan Irreversible Electroporation Ablation Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Southeast Asia Irreversible Electroporation Ablation Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Latin America Irreversible Electroporation Ablation Device Sales Market Share by Country (2021–2032)
 Figure 48. Latin America Irreversible Electroporation Ablation Device Revenue Market Share by Country (2021–2032)
 Figure 49. Mexico Irreversible Electroporation Ablation Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Brazil Irreversible Electroporation Ablation Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Argentina Irreversible Electroporation Ablation Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Colombia Irreversible Electroporation Ablation Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Middle East and Africa Irreversible Electroporation Ablation Device Sales Market Share by Country (2021–2032)
 Figure 54. Middle East and Africa Irreversible Electroporation Ablation Device Revenue Market Share by Country (2021–2032)
 Figure 55. Turkey Irreversible Electroporation Ablation Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Saudi Arabia Irreversible Electroporation Ablation Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 57. UAE Irreversible Electroporation Ablation Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 58. Global Sales Market Share of Irreversible Electroporation Ablation Device by Type (2021–2032)
 Figure 59. Global Revenue Market Share of Irreversible Electroporation Ablation Device by Type (2021–2032)
 Figure 60. Global Irreversible Electroporation Ablation Device Price (K US$/Unit) by Type (2021–2032)
 Figure 61. Global Sales Market Share of Irreversible Electroporation Ablation Device by Application (2021–2032)
 Figure 62. Global Revenue Market Share of Irreversible Electroporation Ablation Device by Application (2021–2032)
 Figure 63. Global Irreversible Electroporation Ablation Device Price (K US$/Unit) by Application (2021–2032)
 Figure 64. Irreversible Electroporation Ablation Device Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS